Pulmonary cavernous hemangiomatosis treated with interferon alfa-2a.
Pulmonary hemangiomatosis is a rare, usually fatal disorder characterized by diffuse proliferation of blood vessels within the thorax. We describe a 7-year-old boy with cavernous-type pulmonary hemangiomatosis successfully treated with interferon alfa-2a. He presented with respiratory distress and hemoptysis that were alleviated during a 2-year follow-up period.
Wu
J M
JM
Department of Pediatrics, National Cheng Kung University Hospital, 138 Sheng-Li Road, Tainan 70428, Taiwan.
Lin
C S
CS
Wang
J N
JN
Luo
C Y
CY
Yu
C Y
CY
Yang
H B
HB
D002648:Child; D004452:Echocardiography; D004562:Electrocardiography; D005500:Follow-Up Studies; D006392:Hemangioma, Cavernous / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008482:Mediastinum / Q000473:pathology; D013902:Radiography, Thoracic; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins